title: Docetaxel-loaded solid lipid nanoparticles as a basis for a targeted and dose-sparing personalized breast cancer treatment strategy.
authors.affiliation: International Translational Medicine and Biomodeling Research Team, MIPT Center for Human Physiology, Laboratory of Cellular and Molecular Technologies, Moscow Institute of Physics and Technology, State University, Moscow, Russia ; Department of Physiology and Basic Pathology, Faculty of Fundamental Medicine, Lomonosov Moscow State University, Moscow, Russia.
authors.forename: Natalia V
authors.initials: NV
authors.lastname: Danilova
authors.affiliation: Department of Human Metabolism, Academic Unit of Reproductive and Developmental Medicine, Sheffield University, Sheffield, UK.
authors.forename: Zhomart R
authors.initials: ZR
authors.lastname: Kalzhanov
authors.affiliation: Department of Physiology and Basic Pathology, Faculty of Fundamental Medicine, Lomonosov Moscow State University, Moscow, Russia.
authors.forename: Nina A
authors.initials: NA
authors.lastname: Nefedova
authors.affiliation: Department of Physiology and Basic Pathology, Faculty of Fundamental Medicine, Lomonosov Moscow State University, Moscow, Russia.
authors.forename: Pavel G
authors.initials: PG
authors.lastname: Mal'kov
authors.affiliation: International Translational Medicine and Biomodeling Research Team, MIPT Center for Human Physiology, Laboratory of Cellular and Molecular Technologies, Moscow Institute of Physics and Technology, State University, Moscow, Russia ; Department of Obstetrics and Gynecology, Ioannina State General Hospital G Chatzikosta, Ioannina, Greece.
authors.forename: Ioannis P
authors.initials: IP
authors.lastname: Kosmas
authors.affiliation: International Translational Medicine and Biomodeling Research Team, MIPT Center for Human Physiology, Laboratory of Cellular and Molecular Technologies, Moscow Institute of Physics and Technology, State University, Moscow, Russia ; Department of Obstetrics, Gynecology and Reproductive Medicine, Peoples' Friendship University of Russia, Moscow, Russia.
authors.forename: Marina Y
authors.initials: MY
authors.lastname: Eliseeva
authors.affiliation: International Translational Medicine and Biomodeling Research Team, MIPT Center for Human Physiology, Laboratory of Cellular and Molecular Technologies, Moscow Institute of Physics and Technology, State University, Moscow, Russia ; Department of Obstetrics, Gynecology and Reproductive Medicine, Peoples' Friendship University of Russia, Moscow, Russia ; Laboratory of Immunology, Moscow State University of Medicine and Dentistry named after AI Evdokimov, Moscow, Russia.
authors.forename: Ospan A
authors.initials: OA
authors.lastname: Mynbaev
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D048271:Chitosan / Q000627:therapeutic use*; D004337:Drug Carriers / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D053758:Nanoparticles / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy*; D043823:Taxoids / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D004337:Drug Carriers; D043823:Taxoids; D048271:Chitosan
references.citation: J Nanosci Nanotechnol. 2010 Nov;10(11):7541-4
references.pmid: 21137978
references.citation: Breast Cancer (Auckl). 2014 Oct 08;8:125-33
references.pmid: 25336961
references.citation: Anticancer Drugs. 2010 Jan;21(1):43-52
references.pmid: 19809300
references.citation: Oncol Rep. 2010 Mar;23(3):717-24
references.pmid: 20127011
references.citation: Nat Rev Drug Discov. 2007 Mar;6(3):231-48
references.pmid: 17330072
references.citation: Nanotoxicology. 2011 Dec;5(4):636-49
references.pmid: 21306192
references.citation: J Control Release. 2003 Sep 4;91(3):417-29
references.pmid: 12932719
references.citation: Int J Pharm. 2009 Sep 8;379(1):174-80
references.pmid: 19524029
references.citation: Future Oncol. 2014;10(9):1649-57
references.pmid: 25145433
references.citation: JAMA. 2014 Sep 3;312(9):902-14
references.pmid: 25182099
references.citation: Crit Rev Ther Drug Carrier Syst. 2009;26(6):523-80
references.pmid: 20402623
references.citation: Eur J Cancer. 2014 Nov;50(16):2752-62
references.pmid: 25168640
references.citation: Expert Opin Pharmacother. 2008 Oct;9(15):2603-16
references.pmid: 18803448
references.citation: Int J Cancer. 2010 Dec 15;127(12):2893-917
references.pmid: 21351269
references.citation: Eur J Cancer Care (Engl). 2016 Mar;25(2):269-79
references.pmid: 25348689
references.citation: Eur J Oncol Nurs. 2009 Feb;13(1):49-59
references.pmid: 19201649
references.citation: CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
references.pmid: 21296855
references.citation: J Pharm Sci. 2008 Aug;97(8):3274-90
references.pmid: 18064681
references.citation: Int J Nanomedicine. 2014;9:4829-46
references.pmid: 25378924
references.citation: J Control Release. 2008 May 22;128(1):23-31
references.pmid: 18374444
references.citation: Biomacromolecules. 2007 Jul;8(7):2250-7
references.pmid: 17579476
references.citation: Oncologist. 2004;9 Suppl 2:24-32
references.pmid: 15161988